Page 2450 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 2450
2188 Part XII Hemostasis and Thrombosis
31. Siegal DM, Curnutte JT, Connolly SJ, et al: Andexanet alfa for the 38. Giugliano RP, Ruff CT, Braunwald E, et al: Edoxaban versus warfarin
reversal of factor Xa inhibitor activity. N Engl J Med 373:2413–2424, in patients with atrial fibrillation. N Engl J Med 369:2093–2104,
2015. 2013.
32. Enriquez A, Lip GY, Baranchuk A: Anticoagulation reversal in the era 39. Buller HR, Decousus H, Grosso M, et al: Edoxaban versus warfarin for
of the non-vitamin K oral anticoagulants. Europace 18:955, 2016. the treatment of symptomatic venous thromboembolism. N Engl J Med
33. Raskob GE, Gallus AS, Pineo GF, et al: Apixaban versus enoxaparin for 369:1406–1415, 2013.
thromboprophylaxis after hip or knee replacement: pooled analysis of 40. Van De Werf F, Adgey J, Ardissino D, et al: Single-bolus tenecteplase
major venous thromboembolism and bleeding in 8464 patients from the compared with front-loaded alteplase in acute myocardial infarction: the
ADVANCE-2 and ADVANCE-3 trials. J Bone Joint Surg Br 94:257–264, ASSENT-2 double-blind randomised trial. Lancet 354:716–722, 1999.
2012. 41. Parsons M, Spratt N, Bivard A, et al: A randomized trial of tenecteplase
34. Agnelli G, Buller HR, Cohen A, et al: Oral apixaban for the treat- versus alteplase for acute ischemic stroke. N Engl J Med 366:1099–1107,
ment of acute venous thromboembolism. N Engl J Med 369:799–808, 2012.
2013. 42. Topol EJ, Ohman EM, Armstrong PW, et al: Survival outcomes 1 year
35. Agnelli G, Buller HR, Cohen A, et al: Apixaban for extended treatment after reperfusion therapy with either alteplase or reteplase for acute myo-
of venous thromboembolism. N Engl J Med 368:699–708, 2013. cardial infarction: results from the Global Utilization of Streptokinase
36. Connolly SJ, Eikelboom J, Joyner C, et al: Apixaban in patients with and t-PA for Occluded Coronary Arteries (GUSTO) III Trial. Circulation
atrial fibrillation. N Engl J Med 364:806–817, 2011. 102:1761–1765, 2000.
37. Granger CB, Alexander JH, McMurray JJ, et al: Apixaban versus warfarin 43. Medcalf RL: Desmoteplase: discovery, insights and opportunities for
in patients with atrial fibrillation. N Engl J Med 365:981–992, 2011. ischaemic stroke. Br J Pharmacol 165:75–89, 2012.
